Similar articles

• Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.

  Aurelian L. Aurelian L. Cancer Res. 1974 May;34(5):1126-35. Cancer Res. 1974. PMID: 4367156 No abstract available.
• Virions and antigens of herpes virus type 2 in cervical carcinoma.

  Aurelian L. Aurelian L. Cancer Res. 1973 Jun;33(6):1539-47. Cancer Res. 1973. PMID: 4352393 No abstract available.
• Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.

  Puthavathana P, Srivatanakul P, Thanapatra S, Kosiyatrakul T, Phitakpraiwan P. Puthavathana P, et al. J Med Assoc Thai. 1980 Oct;63(10):560-7. J Med Assoc Thai. 1980. PMID: 6255050 No abstract available.
• Biochemical approaches to detection of herpes simplex virus type 2 in cervical carcinoma.

  Goodheart CR. Goodheart CR. Cancer Res. 1974 May;34(5):1136-9. Cancer Res. 1974. PMID: 4366987 Review. No abstract available.
• [Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine].

  Nasemann T, Schaeg G. Nasemann T, et al. Hautarzt. 1973 Apr;24(4):133-9. Hautarzt. 1973. PMID: 4351533 Review. German. No abstract available.